Cancer & Oncology News 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 35.
Too Much Sitting May Lower Odds of Surviving Colon Cancer
Study also found that staying active reduced the risk of dying
Source: The Doctors Lounge - Oncology - January 23, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Oncology, Sports Medicine, News, Source Type: news
Moffitt study shows smoking cessation more successful for cancer patients who quit before surgery
(H. Lee Moffitt Cancer Center & Research Institute) Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse.
Source: EurekAlert! - Medicine and Health - January 23, 2013 Category: Global & Universal Source Type: news
Oxygen-free energy designed to fuel brain development spurs on growth of cancer
The metabolic process which fuels the growth of many cancers has its origins in normal brain growth finds a new study. Using knock-out mice the study shows that interfering with Hexokinase-2 (Hk2), an enzyme integral to glucose metabolism, reduces the aggressiveness of medulloblastoma, the most common malignant brain tumor in children, and allows long term survival of mice.
Source: ScienceDaily Headlines - January 22, 2013 Category: Science Source Type: news
Vitamin D may be a breast cancer therapy
ST. LOUIS, Jan. 22 (UPI) -- Vitamin D may be involved in a possible new breast cancer therapy, U.S. and Spanish researchers say.
Source: Health News - UPI.com - January 22, 2013 Category: Consumer Health News Source Type: news
Prostate cancer risk 'has trebled'
Prostate cancer risk has risen to such a degree that one in every seven boys will develop it, figures suggest.
Source: BBC News | Health | UK Edition - January 22, 2013 Category: Consumer Health News Source Type: news
Cervical Cancer Screening in Women Aged 18-30 YearsCervical Cancer Screening in Women Aged 18-30 Years
How often should women in the 18-30 age group undergo screening for cervical cancer? What do the latest guidelines suggest? Morbidity & Mortality Weekly Report
Source: Medscape Today Headlines - January 22, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
Proton vs Intensity-Modulated Radiotherapy for Prostate CancerProton vs Intensity-Modulated Radiotherapy for Prostate Cancer
Learn about differences in toxicity profiles between these two types of prostate cancer radiotherapy. Journal of the National Cancer Institute
Source: Medscape Today Headlines - January 22, 2013 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Are Your Kids Protected from HPV-Related Cancers?
Source: Centers for Disease Control and Prevention
Related MedlinePlus Page: HPV
Source: MedlinePlus Health News - January 22, 2013 Category: Consumer Health News Source Type: news
Lilly stomach cancer drug extends survival vs placebo
(Reuters) - Eli Lilly and Co's stomach cancer drug ramucirumab met its primary goal of improving overall survival in a late stage-study, extending the lives of patients for more than a month longer than those who received a placebo, the American Society of Clinical Oncology said on Tuesday.
Source: Reuters: Health - January 22, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
'Incredibly Promising' Adjuvant Agent for Pancreatic Cancer'Incredibly Promising' Adjuvant Agent for Pancreatic Cancer
The chemotherapy known as S-1 significantly improved survival in pancreatic cancer after surgery, compared with the current standard. Medscape Medical News
Source: Medscape Today Headlines - January 22, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Blood Test Might Help Guide Pancreatic Cancer Treatment
Preliminary results show promise for 'individualized' chemotherapy
Source: The Doctors Lounge - Oncology - January 22, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Hematology, Oncology, Research, News, Source Type: news
A Drug Shows Promise In Treating Pancreatic Cancer
Celgene’s drug Abraxane prolonged the lives of patients with advanced pancreatic cancer by almost two months in a clinical trial, but the gains were not as big as expected.
Source: NYT Health - January 22, 2013 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Pancreatic Cancer Clinical Trials Drugs (Pharmaceuticals) Roche Holding A G RHHBY Other OTC Abraxane Celgene Corporation CELG NASDAQ Abraxis BioScience, Incorporated ABBI NASDAQ Source Type: news
'Fatal' delays in ovarian tests: One in three women waiting six months or more for diagnosis after first seeing their doctor
Revealed in a study by Target Ovarian Cancer, the delay in treatment for the ‘silent killer’ – so-called because it is difficult to diagnose – may have fatal results.
Source: the Mail online | Health - January 22, 2013 Category: Consumer Health News Source Type: news
Prostate cancer rate will TREBLE in a generation to affect one in seven men, warn experts
The ‘alarming’ rise – revealed in figures from Cancer Research UK – is thought to be due to longer lifespans and more widespread testing.
Source: the Mail online | Health - January 22, 2013 Category: Consumer Health News Source Type: news
Women's Smoking Deaths at All-Time High in U.S.
Starting earlier, smoking more account for increase, expert says
Source: Cancercompass News: Other Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news
Too Much Sitting May Lower Odds of Surviving Colon Cancer
Study also found that staying active reduced the risk of dying
Source: HealthDay
Related MedlinePlus Pages: Colorectal Cancer, Exercise and Physical Fitness
Source: MedlinePlus Health News - January 22, 2013 Category: Consumer Health News Source Type: news
VRAM flap success for dorsal vaginal and perineal reconstruction
Reconstruction of the dorsal vagina or perineum using the vertical rectus abdominus myocutaneous flap following extensive surgery and intraoperative radiotherapy for rectal cancer results in favorable surgical and quality of life outcomes, research shows.
Source: MedWire News - Gastroenterology - January 22, 2013 Category: Gastroenterology Source Type: news
Blood Test Might Help Guide Pancreatic Cancer Treatment
Preliminary results show promise for 'individualized' chemotherapy
Source: Cancercompass News: Other Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news
Too Much Sitting May Lower Odds of Surviving Colon Cancer
Study also found that staying active reduced the risk of dying
Source: Cancercompass News: Colorectal Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news
Many Suffer Chronic Pain After Breast Cancer Surgery, Study Finds
Researchers call for better pain management
Source: Cancercompass News: Breast Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news
Celgene's Abraxane Extends Life By 1.8 Months In Advanced Pancreatic Cancer
Abraxane, a cancer chemotherapy made by Celgene, slowed tumor growth and cut the risk of death in patients with advanced pancreatic cancer, according to results that will be presented at a conference on gastrointestinal tumors being held by the American Society of Clinical Oncology.
Source: Forbes.com Healthcare News - January 22, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
Celgene's Abraxane increases survival in pancreatic cancer
(Reuters) - Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly increased the percentage of those who survived with the disease for up to two years, according to a late-stage study.
Source: Reuters: Health - January 22, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Esophageal Ca Survival Jumps with Docetaxel
SAN FRANCISCO (MedPage Today) -- Second-line chemotherapy with docetaxel for esophagogastric cancer led to a greater than 40% improvement in survival compared with only symptomatic treatment, results of a British study showed.
Source: MedPage Today Gastroenterology - January 22, 2013 Category: Gastroenterology Source Type: news
Many Suffer Chronic Pain After Breast Cancer Surgery, Study Finds
Researchers call for better pain management
Source: The Doctors Lounge - Oncology - January 22, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Gynecology, Oncology, Pharmacy, Surgery, News, Source Type: news
Circadian rhythms can be modified for potential treatment of disorders
Studies have revealed the cellular mechanism by which circadian rhythms -- also known as the body clock -- modify energy metabolism and also have identified novel compounds that control this action. The findings point to potential treatments for disorders triggered by circadian rhythm dysfunction, ranging from insomnia and obesity to diabetes and cancer.
Source: ScienceDaily Headlines - January 22, 2013 Category: Science Source Type: news
Many Suffer Chronic Pain After Breast Cancer Surgery, Study Finds
Researchers call for better pain management
Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, Pain
Source: MedlinePlus Health News - January 22, 2013 Category: Consumer Health News Source Type: news
Blood Test Might Spot High-Risk Breast Cancer Genes
Further study is needed, but screen may get around more cumbersome, costly methods, researchers say
Source: The Doctors Lounge - Oncology - January 22, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Oncology, Research, News, Source Type: news
Vitamin D holds promise in battling a deadly breast cancer
Researchers have discovered a molecular pathway that contributes to triple-negative breast cancer, an often deadly and treatment resistant form of cancer that tends to strike younger women. In addition, the team identified vitamin D and some protease inhibitors as possible new therapies and discovered a set of three biomarkers that can help to identify patients who could benefit from the treatment.
Source: ScienceDaily Headlines - January 22, 2013 Category: Science Source Type: news
Radioimmunotherapy as Initial Therapy for LymphomaRadioimmunotherapy as Initial Therapy for Lymphoma
Radioimmunotherapy is approved for use as a consolidation treatment after chemotherapy, but a new trial explores its use as a standalone initial treatment. Medscape Medical News
Source: Medscape Today Headlines - January 22, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Blood Test Might Spot High-Risk Breast Cancer Genes
Further study is needed, but screen may get around more cumbersome, costly methods, researchers say
Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, Genes and Gene Therapy
Source: MedlinePlus Health News - January 22, 2013 Category: Consumer Health News Source Type: news
Breast Cancer Recurrence Predictable With Blood Test
Using a DNA marker that can be obtained via a blood test, researchers in Canada were able accurately to predict which women were more likely to see a recurrence of their breast cancer years later. Although more studies are needed to confirm their findings, they suggest they could complement current prognosis approaches based on tumor assessment. Sambasivarao Damaraju, a professor with the Faculty of Medicine and Dentistry at Canada's University of Alberta, and colleagues, write about their findings in the 16 January issue of the open access online journal PLoS ONE...
Source: Health News from Medical News Today - January 22, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Dual-Tracer PET/CT Better for Liver Transplant Selection
Dual-tracer PET/CT may be more effective than contrast-enhanced CT for staging of hepatocellular carcinoma for evaluation of liver transplant suitability.
Source: Diagnostic Imaging - January 22, 2013 Category: Radiology Source Type: news
Request For Applications: DF/HCC and UMass Boston U54 Partnership to reduce Cancer Disparities
Source: DF/HCC: Latest News - January 22, 2013 Category: Cancer & Oncology Source Type: news
The Gateway for Cancer ResearchSM Receives Generous Donation to...
A $70,000 donation was made by Cancer Sucks in support of Gateway’s mission to fund bold, new phase I and phase II cancer clinical trials that have potential to saves lives today.(PRWeb January 22, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10330004.htm
Source: PRWeb: Medical Pharmaceuticals - January 22, 2013 Category: Pharmaceuticals Source Type: news
New Test Predicted Presence Of Harmful BRCA Mutations
Profile test demonstrated high sensitivity and specificity. Test results could aid in clinical decision making. May provide a quick, affordable alternative to current genetic testing. A new multiple gene expression profile test was able to predict the presence of harmful BRCA1 or BRCA2 mutations in otherwise healthy women carrying the mutations, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research...
Source: Health News from Medical News Today - January 22, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Hospital-based home care can work for children with cancer
Hospital-based home care is a feasible alternative for children with cancer both regarding price and efficacy, show study findings.
Source: MedWire News - Pediatrics - January 22, 2013 Category: Pediatrics Source Type: news
Rice-cell cocktail tough on cancer cells, nice to normal cells
In lab tests, juice from rice cells knocked out two kinds of human cancer cells as well or better than the potent anti-cancer drug Taxol. Plus, it did something extra: it left normal cells unharmed.
Source: ScienceDaily Headlines - January 22, 2013 Category: Science Source Type: news
Y-90 beads extend survival of colon cancer patients
Patients who received radioembolization with yttrium-90 (Y-90) beads for metastatic (more)
Source: AuntMinnie.com Headlines - January 22, 2013 Category: Radiology Source Type: news
Men who go bald by the age of 40 are more likely to get prostate cancer
Australian scientists who studied hair loss patterns in nearly 10,000 men found those who experienced receding hair lines early in life were more likely to suffer a tumour later on.
Source: the Mail online | Health - January 22, 2013 Category: Consumer Health News Source Type: news
IL-22 Provides New Clues to Colon CancerIL-22 Provides New Clues to Colon Cancer
Dr. David Kerr reports research indicating that the IL-22 axis regulates intestinal tissue repair and tumorigenesis in the colon, suggesting a potentially new therapeutic target in colorectal cancer. Medscape Oncology
Source: Medscape Today Headlines - January 22, 2013 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
Trastuzumab: Is Concern for the Heart Warranted?Trastuzumab: Is Concern for the Heart Warranted?
Dr. Lidia Schapira looks at the NSABP B-31 data on the incidence of adverse cardiac events resulting from long-term use of trastuzumab, and comments on who is at higher risk for cardiotoxicity. Medscape Oncology
Source: Medscape ObGyn and Womens Health Headlines - January 22, 2013 Category: OBGYN Tags: Hematology-Oncology Viewpoint Source Type: news
How can evolutionary biology explain why we get cancer?
Over 500 billion cells in our bodies will be replaced daily, yet natural selection has enabled us to develop defenses against the cellular mutations which could cause cancer. It is this relationship between evolution and the body’s fight against cancer which is explored in a new special issue of the Open Access journal Evolutionary Applications.
Source: ScienceDaily Headlines - January 22, 2013 Category: Science Source Type: news
New Golden Retriever study aimed at preventing dog cancer
Almost 3,000 purebred goldens will be tracked for genetic, nutritional and environmental risks over 10-year-period
Source: Health News: CBSNews.com - January 22, 2013 Category: Consumer Health News Source Type: news
Longest study of dog cancer ever conducted
The study will focus on three cancers that can be fatal to the dogs, including bone cancer, lymphoma and a cancer in the blood vessels called hemangiosarcoma
Source: Health News: CBSNews.com - January 22, 2013 Category: Consumer Health News Source Type: news
Verastem Promotes Chief Operating Officer Robert Forrester to President
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Verastem, Inc., (VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, promoted Robert Forrester ... Biopharmaceuticals, Oncology, PersonnelVerastem, Robert Forrester, FAK inhibitor, PI3K/mTOR, VS-6063
Source: HSMN NewsFeed - January 22, 2013 Category: Pharmaceuticals Source Type: news
Men who go bald by the age of 40 are more likely to get prostate cancer
Australian scientists who studied hair loss patterns in nearly 10,000 men found those who experienced receding hair lines early in life were more likely to suffer a tumour later on.
Source: the Mail online | Health - January 22, 2013 Category: Consumer Health News Source Type: news
Bladder cancer risk associated with childbearing factors
The risk for bladder cancer in women may decline with increased parity and older age at first birth, researchers report.
Source: MedWire News - Oncology - January 22, 2013 Category: Cancer & Oncology Source Type: news
MRI ‘good accuracy’ for detecting residual breast cancer
Magnetic resonance imaging is superior to mammography for the detection of residual breast cancer after neoadjuvant chemotherapy, research confirms.
Source: MedWire News - Breast Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news
Men At 'High' Skeletal Risk Prior To Prostate Cancer Hormone Therapy Likely To Have More Fractures After Treatment
Comprehensive Population-Based Study Conducted by Team at The Cancer Institute of New Jersey In what is believed to be the first study to describe the impact on men with a 'high' risk of bone fracture who are receiving long-term androgen deprivation therapy (ADT) for prostate cancer, new research from The Cancer Institute of New Jersey shows this population to have a higher fracture incidence following treatment completion.� The findings, published in the latest online version of BJU International , also show that men who experienced a fracture had a 1...
Source: Health News from Medical News Today - January 22, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
